Bevacizumab, irinotecan, and temozolomide with re-irradiation in adult recurrent medulloblastoma: A first case report

被引：1
|
作者：
Yamauchi, Takahiro [1 ,4 ]
Kitai, Ryuhei [1 ,2 ]
Arai, Hiroshi [3 ]
Kidoguchi, Masamune [3 ]
Isozaki, Makoto [1 ]
Kodera, Toshiaki [1 ]
Kikuta, Ken-ichiro [1 ]
机构：
[1] Univ Fukui, Div Med, Dept Neurosurg, Fac Med Sci, 23-3 Matsuokashimoaizuki,Eiheiji Cho, Fukui 9101193, Japan
[2] Kaga Med Ctr, Dept Neurosurg, Kaga, Ishikawa, Japan
[3] Municipal Tsuruga Hosp, Dept Neurosurg, Tsuruga, Fukui, Japan
[4] Univ Fukui, Dept Hematol & Oncol, Fac Med Sci, Fukui, Japan
来源：
INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT | 2021年 / 25卷
关键词：
Adult recurrent medulloblastoma; Bevacizumab; Irinotecan; Temozolomide; PROGNOSTIC-FACTORS; PHASE-II; CHILDREN; CHEMOTHERAPY; SURVIVAL; THERAPY; TUMOR;
D O I：
10.1016/j.inat.2021.101249
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Medulloblastoma in adults is very rare, and there is no effective therapy for its initial appearance or recurrence. We present a case of a 40-year-old male with recurrent medulloblastoma despite initial radiochemotherapy. He received re-irradiation and 6 courses of bevacizumab, irinotecan, and temozolomide after which he remained stable for 6 months. This regimen may be promising for recurrent medulloblastoma in adults.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Re-irradiation of Pediatric Medulloblastoma: A Case Report and Systematic Review
    Giakoumettis, Georgios
    Mantzavinou, Artemis
    Moschos, Georgios
    Giakoumettis, Dimitrios
    Capizzello, Antonio
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (11)
  • [2] Salvage Re-irradiation Options in Adult Medulloblastoma: A Case Report and Review of the Literature
    Cuccia, Francesco
    Mortellaro, Gianluca
    Ognibene, Lucia
    Craparo, Giuseppe
    Lo Casto, Antonio
    Ferrera, Giuseppe
    IN VIVO, 2020, 34 (03): : 1283 - 1288
  • [3] Dramatic response to temozolomide, irinotecan, and bevacizumab for recurrent medulloblastoma with widespread osseous metastases
    Bonney, Phillip A.
    Santucci, Joshua A.
    Maurer, Adrian J.
    Sughrue, Michael E.
    McNall-Knapp, Rene Y.
    Battiste, James D.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2016, 26 : 161 - 163
  • [4] Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial
    Levy, Adam S.
    Krailo, Mark
    Chi, Susan
    Villaluna, Doojduen
    Springer, Linda
    Williams-Hughes, Chris
    Fouladi, Maryam
    Gajjar, Amar
    PEDIATRIC BLOOD & CANCER, 2021, 68 (08)
  • [5] Notable response of a young adult with recurrent glioblastoma multiforme to vincristine-irinotecan-temozolomide and bevacizumab
    Papageorgiou, Georgios, I
    Tsakatikas, Sergios A.
    Fioretzaki, Rodanthi G.
    Kosmas, Christos
    ANTI-CANCER DRUGS, 2021, 32 (03) : 330 - 336
  • [6] Bevacizumab combined with re-irradiation in recurrent glioblastoma
    She, Lei
    Su, Lin
    Liu, Chao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Craniospinal irradiation as part of re-irradiation for children with recurrent medulloblastoma
    Baroni, Lorena, V
    Freytes, Candela
    Fernandez Ponce, Nicolas
    Oller, Agustina
    Pinto, Natalia
    Gonzalez, Adriana
    Maldonado, Francisco R.
    Sampor, Claudia
    Rugilo, Carlos
    Lubieniecki, Fabiana
    Alderete, Daniel
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (01) : 53 - 61
  • [8] Bevacizumab and Irinotecan in the Treatment of Children With Recurrent/Refractory Medulloblastoma
    Aguilera, Dolly G.
    Goldman, Steward
    Fangusaro, Jason
    PEDIATRIC BLOOD & CANCER, 2011, 56 (03) : 491 - 494
  • [9] Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma
    Schnell, Oliver
    Thorsteinsdottir, Jun
    Fleischmann, Daniel Felix
    Lenski, Markus
    Abenhardt, Wolfgang
    Giese, Armin
    Tonn, Joerg-Christian
    Belka, Claus
    Kreth, Friedrich Wilhelm
    Niyazi, Maximilian
    JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (03) : 591 - 599
  • [10] A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
    Dixit, Karan S.
    Sachdev, Sean
    Amidei, Christina
    Kumthekar, Priya
    Kruser, Tim J.
    Gondi, Vinai
    Grimm, Sean
    Lukas, Rimas, V
    Nicholas, Martin Kelly
    Chmura, Steven J.
    Fought, Angela J.
    Mehta, Minesh
    Raizer, Jeffrey J.
    JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (03) : 297 - 306
12345